North America Cancer Radiation Therapy Market Outlook (2021–2031)
The North America cancer radiation therapy market size is expected to reach US$ 55,989.1 million by 2031 from US$ 24,028.1 million in 2024. The market is estimated to record a CAGR of 13.0% from 2025 to 2031.
Report Coverage
- Type: External Beam Radiation Therapy, Internal Beam Radiation Therapy
- Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Head & Neck Cancer, Cervical Cancer, Other Cancer Types
- End User: Hospitals, Specialty Clinics, Ambulatory and Radiotherapy Centers, Academic and Research Institutes
US$ 24,028.1 Mn
Market size in 2024
US$ 55,989.1 Mn
Market Size by 2031
13.0%
CAGR, 2025 - 2031
2025-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Cancer Radiation Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Cancer Radiation Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Cancer Radiation Therapy Market Regional Analysis
6.2 North America Cancer Radiation Therapy Market Revenue 2021-2031 (US$ Million)
6.3 North America Cancer Radiation Therapy Market Forecast Analysis
7. North America Cancer Radiation Therapy Market Analysis – by Type
7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Cancer Radiation Therapy Market Analysis – by Cancer Type
8.1 Lung Cancer
- 8.1.1 Overview
- 8.1.2 Lung Cancer: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Breast Cancer
- 8.2.1 Overview
- 8.2.2 Breast Cancer: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Colorectal Cancer
- 8.3.1 Overview
- 8.3.2 Colorectal Cancer: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Prostate Cancer
- 8.4.1 Overview
- 8.4.2 Prostate Cancer: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Head & Neck Cancer
- 8.5.1 Overview
- 8.5.2 Head & Neck Cancer: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Cervical Cancer
- 8.6.1 Overview
- 8.6.2 Cervical Cancer: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Other Cancer Types
- 8.7.1 Overview
- 8.7.2 Other Cancer Types: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Cancer Radiation Therapy Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ambulatory and Radiotherapy Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory and Radiotherapy Centers: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: North America Cancer Radiation Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Cancer Radiation Therapy Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Cancer Radiation Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
- 10.2.1.1 North America Cancer Radiation Therapy Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 US: North America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.1.2 US: North America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.1.3 US: North America Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.2 Canada: North America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Canada: North America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.2.3 Canada: North America Cancer Radiation Therapy Market Breakdown, by End User
- 10.2.1.3 Mexico: North America Cancer Radiation Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Mexico: North America Cancer Radiation Therapy Market Breakdown, by Type
- 10.2.1.3.2 Mexico: North America Cancer Radiation Therapy Market Breakdown, by Cancer Type
- 10.2.1.3.3 Mexico: North America Cancer Radiation Therapy Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Siemens Healthineers
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Accuray Incorporated
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Elekta
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Brainlab AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 RefleXion
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Hitachi Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 IBA Worldwide
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 GT Medical Technologies, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Mevion Medical Systems
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Theragenics Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
